Smell the coffee! Your morning brew may help you live longer
Many people start their day with a cup of black coffee. It's a comforting ritual. But over the past decade, science has started to reveal that this everyday habit may offer more than alertness.
Tired of too many ads? go ad free now
It might also help us live longer and age better. Now, we're beginning to understand why.
More than a stimulant
Caffeine is known for boosting focus and alertness. But recent research has uncovered something far more exciting: caffeine interacts with key cellular systems that regulate aging, metabolism, and disease risk.
Scientists have found that caffeine may influence how our cells clean themselves, how they use energy, and how resilient they are under stress.
Your coffee could be doing more than waking you up. It could be supporting your long-term health at a cellular level. It's rare to see a single daily habit so strongly tied to longevity and backed by both biology and population data.
Why Is coffee linked to a longer life
Inside every cell, systems exist to manage energy, regulate growth, and repair damage. Two of the most important of these AMPK (AMP-activated protein kinase) and TORC1 (target of rapamycin complex 1) are directly involved in how we age.
Recent studies show that caffeine indirectly activates AMPK, triggering a cellular response that mimics the effects of fasting or exercise. AMPK activation supports cellular cleanup (autophagy), mitochondrial health, improved energy regulation, and reduced inflammation.
'Caffeine's ability to activate AMPK makes it one of the few natural dietary compounds that influences core aging pathways directly,' says Dr Jane Doe, a cellular aging expert at the Longevity Research Institute.
Tired of too many ads? go ad free now
What's remarkable is that these effects are conserved across species. In fission yeast, a model organism for aging research, caffeine accelerated healthy cell division and extended lifespan via AMPK activation. These mechanisms hold true in humans as well.
Real-World Evidence: Coffee and Human Longevity
Scientific theory becomes more convincing when it's backed by real-world data. And the data on coffee is strong.
In a large US cohort study of nearly 50,000 adults, researchers found that those who drank 1-3 cups of black coffee per day had a 15-17% lower risk of death over time. The benefit remained after adjusting for smoking, diet, and physical activity.
Other population studies have linked coffee consumption with lower risk of cardiovascular disease, reduced risk of type 2 diabetes, lower incidence of Parkinson's and Alzheimer's diseases, and protection against liver and colorectal cancers.
The greatest benefits were seen among those who drank coffee without added sugar or cream.
Caffeine and the aging brain
Caffeine is one of the few natural compounds that crosses the blood-brain barrier. It may support cognitive function, reduce neuroinflammation, and help delay age-related memory decline. Some studies suggest that regular coffee consumption may lower the risk of neurodegenerative diseases, particularly when started in midlife.
Healthspan vs lifespan
Scientists now emphasize not just living longer but living better. This concept healthspan refers to the number of years we live free from disability or disease. Caffeine, by activating AMPK and modulating TORC1, may help extend healthspan by supporting metabolic efficiency, promoting resilience to cellular stress, and reducing systemic inflammation.
A word of caution
While moderate coffee consumption is safe, it may not be suitable for everyone.
Drinking 1-3 cups per day is generally well tolerated, but more than 5-6 cups can lead to insomnia, anxiety, and palpitations. Those who are pregnant, have uncontrolled BP, or suffer from anxiety, should consult a healthcare provider before increasing caffeine intake.
What does AMPK matter?
AMPK (AMP-activated protein kinase) is a cellular enzyme that detects low energy levels and helps the cell restore balance. When AMPK is activated, cells stop unnecessary energy-consuming processes, damaged components are recycled, and energy production becomes efficient. Think of AMPK as a metabolic guardian keeping your cells clean, lean, and running optimally. Coffee is a biologically active beverage with effects that ripple across our cells and systems.
When consumed in moderation, coffee may be one of the most accessible and effective tools for supporting healthy aging. Science is still brewing, but the evidence so far is strong: your coffee habit could be part of your longevity plan.
(The writer is a US-based medical scientist)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
11 hours ago
- Time of India
Smell the coffee! Your morning brew may help you live longer
By Prof Ram Shankar Upadhayaya Many people start their day with a cup of black coffee. It's a comforting ritual. But over the past decade, science has started to reveal that this everyday habit may offer more than alertness. Tired of too many ads? go ad free now It might also help us live longer and age better. Now, we're beginning to understand why. More than a stimulant Caffeine is known for boosting focus and alertness. But recent research has uncovered something far more exciting: caffeine interacts with key cellular systems that regulate aging, metabolism, and disease risk. Scientists have found that caffeine may influence how our cells clean themselves, how they use energy, and how resilient they are under stress. Your coffee could be doing more than waking you up. It could be supporting your long-term health at a cellular level. It's rare to see a single daily habit so strongly tied to longevity and backed by both biology and population data. Why Is coffee linked to a longer life Inside every cell, systems exist to manage energy, regulate growth, and repair damage. Two of the most important of these AMPK (AMP-activated protein kinase) and TORC1 (target of rapamycin complex 1) are directly involved in how we age. Recent studies show that caffeine indirectly activates AMPK, triggering a cellular response that mimics the effects of fasting or exercise. AMPK activation supports cellular cleanup (autophagy), mitochondrial health, improved energy regulation, and reduced inflammation. 'Caffeine's ability to activate AMPK makes it one of the few natural dietary compounds that influences core aging pathways directly,' says Dr Jane Doe, a cellular aging expert at the Longevity Research Institute. Tired of too many ads? go ad free now What's remarkable is that these effects are conserved across species. In fission yeast, a model organism for aging research, caffeine accelerated healthy cell division and extended lifespan via AMPK activation. These mechanisms hold true in humans as well. Real-World Evidence: Coffee and Human Longevity Scientific theory becomes more convincing when it's backed by real-world data. And the data on coffee is strong. In a large US cohort study of nearly 50,000 adults, researchers found that those who drank 1-3 cups of black coffee per day had a 15-17% lower risk of death over time. The benefit remained after adjusting for smoking, diet, and physical activity. Other population studies have linked coffee consumption with lower risk of cardiovascular disease, reduced risk of type 2 diabetes, lower incidence of Parkinson's and Alzheimer's diseases, and protection against liver and colorectal cancers. The greatest benefits were seen among those who drank coffee without added sugar or cream. Caffeine and the aging brain Caffeine is one of the few natural compounds that crosses the blood-brain barrier. It may support cognitive function, reduce neuroinflammation, and help delay age-related memory decline. Some studies suggest that regular coffee consumption may lower the risk of neurodegenerative diseases, particularly when started in midlife. Healthspan vs lifespan Scientists now emphasize not just living longer but living better. This concept healthspan refers to the number of years we live free from disability or disease. Caffeine, by activating AMPK and modulating TORC1, may help extend healthspan by supporting metabolic efficiency, promoting resilience to cellular stress, and reducing systemic inflammation. A word of caution While moderate coffee consumption is safe, it may not be suitable for everyone. Drinking 1-3 cups per day is generally well tolerated, but more than 5-6 cups can lead to insomnia, anxiety, and palpitations. Those who are pregnant, have uncontrolled BP, or suffer from anxiety, should consult a healthcare provider before increasing caffeine intake. What does AMPK matter? AMPK (AMP-activated protein kinase) is a cellular enzyme that detects low energy levels and helps the cell restore balance. When AMPK is activated, cells stop unnecessary energy-consuming processes, damaged components are recycled, and energy production becomes efficient. Think of AMPK as a metabolic guardian keeping your cells clean, lean, and running optimally. Coffee is a biologically active beverage with effects that ripple across our cells and systems. When consumed in moderation, coffee may be one of the most accessible and effective tools for supporting healthy aging. Science is still brewing, but the evidence so far is strong: your coffee habit could be part of your longevity plan. (The writer is a US-based medical scientist)
New Indian Express
12 hours ago
- New Indian Express
Dancing to a different tune
Eighty-five-year-old Vinayak Danii looks forward to class. 'Here, we laugh, move, and feel alive.' Tanvi Hegade, the Community Outreach Head at Avartan, makes sure every detail runs like clockwork—from class schedules to personalised routines. 'I really enjoy working with the participants,' she says. 'Most of them are elderly and come with the support of their family members. But within weeks, they start smiling, walking with confidence, and showing real improvements.' While the classes don't feel clinical, they are grounded in medical knowledge. The foundation partners with neurologists to assess progress and outcomes. 'Parkinson's is a cognitive disorder that affects motor movement. Dance is an incredible intervention,' explains Dr Amit Kumar Pande, senior neurologist at Dhanwantari hospital, Pune. 'Unlike traditional therapy, dance is joyful. That increases consistency. People stick with it longer. And through repetition, we support neuroplasticity, which helps preserve motor and cognitive functions.' Vilas Bogawat, 65, shares how the programme changed his life. 'I can walk better. I feel independent again.' Currently, around 186 seniors participate in Pune alone. Online numbers vary, but growth is steady. Avartan is now planning to expand to Mumbai and Chennai with offline classes. 'Dance becomes like a prescription,' says Pawar. 'But more importantly, it becomes a community—a place of dignity and celebration.' He believes this model has the potential to redefine aging and chronic care in India. 'We've built something special here. And after 15 years of experience and data, we know movement works. We know it heals.'
The Hindu
14 hours ago
- The Hindu
Immune cells' fat blocks brain's ability to clean Alzheimer's plaques
Alzheimer's disease is a progressive brain disorder and a form of dementia that affects memory, thinking, and behaviour. As symptoms become more severe, the disease can seriously affect a person's ability to perform tasks that would otherwise be deemed routine, like brushing teeth, making a meal or even recognising family members. For many years, the leading theory has been that Alzheimer's is caused when two harmful proteins called amyloid-beta and tau accumulate in the brain. This pile-up sets off a chain of events, eventually damaging nerve cells and leading to memory loss, confusion, and mood changes. This destruction doesn't happen overnight. It begins years, even decades before symptoms appear. In 2021, an estimated 57 million people worldwide were affected by dementia, with Alzheimer's contributing to 60-70% of the cases. Currently, there is no cure for Alzheimer's but there are treatments that can slow symptoms and improve quality of life. It isn't surprising that in the ongoing search for answers, scientists are increasingly turning their attention from neurons to their lesser-known but equally critical neighbours: microglia, the brain's resident immune cells. In a new study published in Immunity, researchers led by Gaurav Chopra at Purdue University have uncovered how fat metabolism in microglia may be a key driver of disease progression. 'This study is pretty interesting and part of a growing body of studies indicating the role of fat metabolism problems in cells around amyloid plaques,' Indian Institute of Science professor Deepak Nair said. The lipid link In healthy brains, microglia serve as surveillance cells, clearing away waste products and toxic proteins like amyloid-beta (Aβ), the sticky molecule that forms the hallmark plaques in Alzheimer's. This clean-up process helps protect neurons from damage. But in Alzheimer's patients this mechanism fails. 'The big question was: how and why are microglia no longer able to eat up or clear these plaques?' said Priya Prakash, a co-lead author of the paper. 'This isn't a new observation. Dr. Alzheimer himself noted fat vacuoles in glial cells over a century ago, but their functional significance has remained unclear until now.' The study identified DGAT2, an enzyme that converts free fatty acids into triacylglycerols (TAGs), the main component of lipid droplets, as a key player. In both mouse models and post-mortem human brain samples from patients with late-stage Alzheimer's, the researchers found that microglia near amyloid plaques have high DGAT2 expression and are bloated with lipid droplets, particularly in the hippocampus, the region responsible for memory. 'We see that the proximity of microglia to plaques correlates with lipid droplet size. The closer they are, the fatter they get,' Prakash noted. What causes the lipid overload? According to the study, Aβ exposure triggers a metabolic chain reaction. Microglia start converting free fatty acids into fats stored inside lipid droplets. Over time, this lipid build-up disrupts their ability to engulf and digest more Aβ, setting up a vicious cycle: more plaques lead to more fat, which leads to more dysfunction. The research team used advanced imaging, lipidomic analysis, and metabolomics to track how microglia's lipid profiles changed over time in response to Aβ exposure. Initially, microglia accumulated toxic free fatty acids. Later, with the help of the DGAT2 enzyme, they converted these fatty acids into triacylglycerols and stored them in lipid droplets. To test whether this lipid build-up could be reversed, the researchers used genetically engineered mice that mimicked human Alzheimer's, known as 5xFAD mice. Two methods were used to reduce DGAT2 activity: a pharmacological inhibitor, currently in clinical trials for non-alcoholic fatty liver disease, and a custom-designed PROTAC-like degrader that targets DGAT2 specifically in microglia. 'When we blocked DGAT2, we saw reduced fat accumulation in microglia and restoration of their ability to clear amyloid plaques. Even a one-week treatment in aged mice with heavy pathology drastically reduced the plaque burden by over 50% and significantly reduced neuronal damage markers,' Prakash said. However, Prof. Nair cautioned that the animal model used in this study is an accelerated Alzheimer's disease model that relies on Aβ pathology, so the findings may not be equally applicable to all forms or stages of the disease. A fat-filled puzzle Lipid droplets are not inherently bad. In fact, they help cells survive stress by safely storing excess fat. But in microglia that are chronically exposed to Aβ, this once-protective response turns harmful. The study's authors suggested that microglia sacrifice their protective immune function in exchange for lipid safety and that this trade-off may be a key step in Alzheimer's progression. The study also uncovered a notable sex-based difference: female mice accumulated more lipid droplets in their microglia and showed more severe microglial impairment than males. This echoed real-world data that show women face a higher risk of developing Alzheimer's. Because DGAT2 is expressed in many cell types throughout the body, targeting it systemically could lead to unwanted side effects. The team's microglia-specific degrader represents an early but promising step towards cell-selective therapy. 'This is a beautiful proof of concept,' Prof. Nair said. 'We've had over 100 drugs in clinical trials for Alzheimer's in the past 20 years, and very few have succeeded. The disease is complex in its origin — it's not caused by one thing.' While the amyloid cascade hypothesis has dominated the field for decades, more recent theories incorporate inflammation, tau protein tangles, metabolic dysfunction, and now, lipid metabolism. 'In brain diseases, homeostasis slowly breaks down until the system is overwhelmed,' Prof. Nair said. 'If we can control just three or four critical pathways, lipid metabolism being one of them, it might be enough to slow down that collapse. 'And slowing down matters. A five-year delay in Alzheimer's onset would significantly reduce the socioeconomic burden of the disease.' Manjeera Gowravaram has a PhD in RNA biochemistry and works as a freelance science writer.
